Abstract : Rhamnolipid PS-17 is ramnose-containing glicolipid and biosurfactant pro- duced by Pseudomonas sp. S-17. The biosurfactant activity has been deter- mined against herpes simplex virus type 2 (HSV-2) in vitro. No inactivation of virus infectivity after pretreatment with rhamnolipid PS-17 was observed. The compound in concentrations below its critical micelle concentration was found to be an active inhibitor of HSV-2 replication in Madin-Darby bovine kidney cells (MDBK). Thus, rhamnolipid PS-17 is perspective for a combined therapy of virus infections.
https://hal-riip.archives-ouvertes.fr/pasteur-00748962
Contributor : Petar Grozdanov
<>
Submitted on : Tuesday, November 6, 2012 - 1:07:53 PM
Last modification on : Monday, October 8, 2018 - 5:44:06 PM
Long-term archiving on : Saturday, December 17, 2016 - 7:43:02 AM
File
Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed
until : jamais
Ana Ivanova, Elena Karpenko, Angel S. Galabov, Mimi Remichkova. EFFECT OF PSEUDOMONAS SP. S-17 RHAMNOLIPID ON HERPES SIMPLEX VIRUS TYPE 2. Comptes rendus de l'Académie bulgare des Sciences, Bulgarian Academy of Sciences, 2010, 64 (1), pp.157-160. ⟨pasteur-00748962⟩
